TradingView
SimplyCash
28 de Ene. de 2021 14:42

Great pullback - now the fun begins Largo

NASDAQ:CRSP1D
CRISPR Therapeutics AGNASDAQ

Descripción

⋅
CRSP is leader in Genomics and this recent pullback is a perfect buying opportunity for new entrants. If our Elliott wave impulse thesis plays out, the next target could be $290. LONG
Trend AnalysisChart PatternsWave Analysis
Comentarios
johnpfeifer4
⋅
Nice chart, looking good so far!
Más